Previous studies have indicated that sarcopenia is associated with poor post-operative outcomes in liver cancer patients, but the studies are limited by confounding from mixed diseases, retrospective data, and non-standardized measurement methods. At present, there is no research with both muscle mass and strength as predictors for hepatocellular carcinoma (HCC) outcomes. We studied the impact of sarcopenia on post-operative outcomes in HCC patients in a cohort study designed according to the European Working Group on Sarcopenia in Older People standards.

中文翻译：

---

肌肉减少症对肝细胞癌肝切除患者预后的影响

先前的研究表明，肌肉减少症与肝癌患者术后不良预后相关，但研究受到混合疾病、回顾性数据和非标准化测量方法的混杂限制。目前，没有研究将肌肉质量和力量作为肝细胞癌 (HCC) 预后的预测因子。我们在根据欧洲老年人肌肉减少症工作组标准设计的队列研究中研究了肌肉减少症对 HCC 患者术后结局的影响。